Novartis Investigative Site

Gifu 5008513

0 studies enrolling now · 2 studies all time

What they study most

Myelodysplastic Syndromes, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). — Stopped early